Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 20.14 is 25% above its 5-year average of 16.18, around the middle of its 5-year range (4.87–36.28).
As of the fiscal period ended Tuesday, June 30, 2026. 18.36% above its 12-month average of 17.02.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 20.14.
CURRENT RATIO
20.14
CURRENT RATIO AVG TTM
17.02
CURRENT RATIO AVG 3Y
12.21
CURRENT RATIO AVG 5Y
16.18
CURRENT RATIO AVG 10Y
14.46
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+18.36%
CURRENT VS 3Y AVG
+65.00%
CURRENT VS 5Y AVG
+24.53%
CURRENT VS 10Y AVG
+39.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+437.18%
vs the sector median at left
Minerva Neurosciences, Inc.
Market Cap
$160.50M
Current Ratio
20.14
TTM Avg
17.02
3Y Avg
12.21
5Y Avg
16.18
Market Cap
$156.62M
Current Ratio
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $160.50M | 20.14 | 17.02 | 12.21 | 16.18 |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | 1.77 | 1.33 | 1.71 | 2.63 |
| PepGen Inc. (PEPG)vs › | $159.44M | 13.36 | 9.68 | 8.92 | 10.26 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.90 | 1.03 | 0.91 | 1.08 |
| Quanterix Corporation (QTRX)vs › | $162.44M | 3.40 | 5.75 | 8.37 | 8.52 |
| Inogen, Inc. (INGN)vs › | $156.90M | 2.74 | 2.77 | 3.26 | 3.97 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $156.62M | 0.45 | 0.24 | 0.20 | 0.38 |
| Nkarta, Inc. (NKTX)vs › | $164.91M | 7.98 | 13.57 | 13.59 | 18.24 |
| OptimizeRx Corp. (OPRX)vs › | $165.17M | 5.58 | 2.96 | 5.18 | 6.05 |
| Cue Biopharma, Inc. (CUE)vs › | $166.54M | 1.25 | 2.29 | 3.57 | 4.16 |
Current Ratio
20.14
Quick Ratio
20.14
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 20.14 |
| 2026-03-31 | 17.65 |
| 2025-12-31 | 36.28 |
| 2025-09-30 | 4.87 |
| 2025-06-30 | 6.15 |
| 2025-03-31 | 9.21 |
| 2024-12-31 | 7.85 |
| 2024-09-30 | 6.23 |
| 2024-06-30 | 7.47 |
| 2024-03-31 | 12.58 |
| 2023-12-31 | 12.57 |
| 2023-09-30 | 14.40 |
| 2023-06-30 | 27.37 |
| 2023-03-31 | 14.66 |
| 2022-12-31 | 29.15 |
| 2022-09-30 | 20.41 |
| 2022-06-30 | 14.68 |
| 2022-03-31 | 17.15 |
| 2021-12-31 | 22.07 |
| 2021-09-30 | 21.88 |
| 2021-06-30 | 16.93 |
| 2021-03-31 | 24.32 |
| 2020-12-31 | 8.68 |
| 2020-09-30 | 6.49 |
| 2020-06-30 | 4.85 |
| 2020-03-31 | 5.40 |
| 2019-12-31 | 7.11 |
| 2019-09-30 | 6.21 |
| 2019-06-30 | 9.34 |
| 2019-03-31 | 11.64 |
| 2018-12-31 | 24.94 |
| 2018-09-30 | 26.20 |
| 2018-06-30 | 22.28 |
| 2018-03-31 | 15.84 |
| 2017-12-31 | 18.94 |
| 2017-09-30 | 15.38 |
| 2017-06-30 | 5.35 |
| 2017-03-31 | 6.64 |
| 2016-12-31 | 8.66 |
| 2016-09-30 | 9.17 |
| 2016-06-30 | 15.62 |
| 2016-03-31 | 6.51 |
| 2015-12-31 | 6.29 |
| 2015-09-30 | 12.09 |
| 2015-06-30 | 9.38 |
| 2015-03-31 | 11.92 |
| 2014-12-31 | 5.51 |
| 2014-09-30 | 7.62 |
| 2014-06-30 | 0.05 |
| 2014-03-31 | 0.41 |
| 2013-12-31 | 1.29 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
